The use of interim buprenorphine in people on a waiting list to enter treatment for opioid abuse resulted in dramatically less illicit opioid use than in people without interim therapy, according to a study that was highlighted in correspondence to the editor in the Dec. 22 edition of The New England Journal of Medicine (2016;375:2504-2505).
The primary outcome of the study was the percentage of urine specimens that tested negative for illicit opioids in 25 patients who received the opioid